Tag Archive for: CatalYm GmbH

Catalym
Financing round

Catalym raises US$150m

German cancer specialist Catalym GmbH has raised US$150m to finance proof-of-concept studies.

Read more
financing

CatalYm GmbH raises €50m to push visugromab development

Munich-based immunooncology specialist CatalYm GmbH wants to use €50m from a Series C financing round to advance its anti-GDF15 antibody to Phase II development.

Read more